2025-04-012026-03-312026-03-31false05833102HERTS HEALTH LIMITED2026-06-24falseiso4217:GBPxbrli:pure058331022025-03-31058331022026-03-31058331022025-04-012026-03-31058331022024-03-31058331022025-03-31058331022024-04-012025-03-3105833102bus:SmallEntities2025-04-012026-03-3105833102bus:AuditExempt-NoAccountantsReport2025-04-012026-03-3105833102bus:AbridgedAccounts2025-04-012026-03-3105833102bus:PrivateLimitedCompanyLtd2025-04-012026-03-3105833102core:WithinOneYear2026-03-3105833102core:AfterOneYear2026-03-3105833102core:WithinOneYear2025-03-3105833102core:AfterOneYear2025-03-3105833102core:ShareCapital2026-03-3105833102core:SharePremium2026-03-3105833102core:RevaluationReserve2026-03-3105833102core:OtherReservesSubtotal2026-03-3105833102core:RetainedEarningsAccumulatedLosses2026-03-3105833102core:ShareCapital2025-03-3105833102core:SharePremium2025-03-3105833102core:RevaluationReserve2025-03-3105833102core:OtherReservesSubtotal2025-03-3105833102core:RetainedEarningsAccumulatedLosses2025-03-3105833102core:LandBuildings2026-03-3105833102core:PlantMachinery2026-03-3105833102core:Vehicles2026-03-3105833102core:FurnitureFittings2026-03-3105833102core:OfficeEquipment2026-03-3105833102core:NetGoodwill2026-03-3105833102core:IntangibleAssetsOtherThanGoodwill2026-03-3105833102core:ListedExchangeTraded2026-03-3105833102core:UnlistedNon-exchangeTraded2026-03-3105833102core:LandBuildings2025-03-3105833102core:PlantMachinery2025-03-3105833102core:Vehicles2025-03-3105833102core:FurnitureFittings2025-03-3105833102core:OfficeEquipment2025-03-3105833102core:NetGoodwill2025-03-3105833102core:IntangibleAssetsOtherThanGoodwill2025-03-3105833102core:ListedExchangeTraded2025-03-3105833102core:UnlistedNon-exchangeTraded2025-03-3105833102core:LandBuildings2025-04-012026-03-3105833102core:PlantMachinery2025-04-012026-03-3105833102core:Vehicles2025-04-012026-03-3105833102core:FurnitureFittings2025-04-012026-03-3105833102core:OfficeEquipment2025-04-012026-03-3105833102core:NetGoodwill2025-04-012026-03-3105833102core:IntangibleAssetsOtherThanGoodwill2025-04-012026-03-3105833102core:ListedExchangeTraded2025-04-012026-03-3105833102core:UnlistedNon-exchangeTraded2025-04-012026-03-3105833102core:MoreThanFiveYears2025-04-012026-03-3105833102core:Non-currentFinancialInstruments2026-03-3105833102core:Non-currentFinancialInstruments2025-03-3105833102dpl:CostSales2025-04-012026-03-3105833102dpl:DistributionCosts2025-04-012026-03-3105833102core:LandBuildings2025-04-012026-03-3105833102core:PlantMachinery2025-04-012026-03-3105833102core:Vehicles2025-04-012026-03-3105833102core:FurnitureFittings2025-04-012026-03-3105833102core:OfficeEquipment2025-04-012026-03-3105833102dpl:AdministrativeExpenses2025-04-012026-03-3105833102core:NetGoodwill2025-04-012026-03-3105833102core:IntangibleAssetsOtherThanGoodwill2025-04-012026-03-3105833102dpl:GroupUndertakings2025-04-012026-03-3105833102dpl:ParticipatingInterests2025-04-012026-03-3105833102dpl:GroupUndertakingscore:ListedExchangeTraded2025-04-012026-03-3105833102core:ListedExchangeTraded2025-04-012026-03-3105833102dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-04-012026-03-3105833102core:UnlistedNon-exchangeTraded2025-04-012026-03-3105833102dpl:CostSales2024-04-012025-03-3105833102dpl:DistributionCosts2024-04-012025-03-3105833102core:LandBuildings2024-04-012025-03-3105833102core:PlantMachinery2024-04-012025-03-3105833102core:Vehicles2024-04-012025-03-3105833102core:FurnitureFittings2024-04-012025-03-3105833102core:OfficeEquipment2024-04-012025-03-3105833102dpl:AdministrativeExpenses2024-04-012025-03-3105833102core:NetGoodwill2024-04-012025-03-3105833102core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3105833102dpl:GroupUndertakings2024-04-012025-03-3105833102dpl:ParticipatingInterests2024-04-012025-03-3105833102dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3105833102core:ListedExchangeTraded2024-04-012025-03-3105833102dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3105833102core:UnlistedNon-exchangeTraded2024-04-012025-03-3105833102core:NetGoodwill2026-03-3105833102core:IntangibleAssetsOtherThanGoodwill2026-03-3105833102core:LandBuildings2026-03-3105833102core:PlantMachinery2026-03-3105833102core:Vehicles2026-03-3105833102core:FurnitureFittings2026-03-3105833102core:OfficeEquipment2026-03-3105833102core:AfterOneYear2026-03-3105833102core:WithinOneYear2026-03-3105833102core:ListedExchangeTraded2026-03-3105833102core:UnlistedNon-exchangeTraded2026-03-3105833102core:ShareCapital2026-03-3105833102core:SharePremium2026-03-3105833102core:RevaluationReserve2026-03-3105833102core:OtherReservesSubtotal2026-03-3105833102core:RetainedEarningsAccumulatedLosses2026-03-3105833102core:NetGoodwill2025-03-3105833102core:IntangibleAssetsOtherThanGoodwill2025-03-3105833102core:LandBuildings2025-03-3105833102core:PlantMachinery2025-03-3105833102core:Vehicles2025-03-3105833102core:FurnitureFittings2025-03-3105833102core:OfficeEquipment2025-03-3105833102core:AfterOneYear2025-03-3105833102core:WithinOneYear2025-03-3105833102core:ListedExchangeTraded2025-03-3105833102core:UnlistedNon-exchangeTraded2025-03-3105833102core:ShareCapital2025-03-3105833102core:SharePremium2025-03-3105833102core:RevaluationReserve2025-03-3105833102core:OtherReservesSubtotal2025-03-3105833102core:RetainedEarningsAccumulatedLosses2025-03-3105833102core:NetGoodwill2024-03-3105833102core:IntangibleAssetsOtherThanGoodwill2024-03-3105833102core:LandBuildings2024-03-3105833102core:PlantMachinery2024-03-3105833102core:Vehicles2024-03-3105833102core:FurnitureFittings2024-03-3105833102core:OfficeEquipment2024-03-3105833102core:AfterOneYear2024-03-3105833102core:WithinOneYear2024-03-3105833102core:ListedExchangeTraded2024-03-3105833102core:UnlistedNon-exchangeTraded2024-03-3105833102core:ShareCapital2024-03-3105833102core:SharePremium2024-03-3105833102core:RevaluationReserve2024-03-3105833102core:OtherReservesSubtotal2024-03-3105833102core:RetainedEarningsAccumulatedLosses2024-03-3105833102core:AfterOneYear2025-04-012026-03-3105833102core:WithinOneYear2025-04-012026-03-3105833102core:Non-currentFinancialInstrumentscore:CostValuation2025-04-012026-03-3105833102core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-04-012026-03-3105833102core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-04-012026-03-3105833102core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-04-012026-03-3105833102core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-04-012026-03-3105833102core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-04-012026-03-3105833102core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3105833102core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3105833102core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3105833102core:Non-currentFinancialInstrumentscore:CostValuation2026-03-3105833102core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2026-03-3105833102core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2026-03-3105833102core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2026-03-3105833102core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2026-03-3105833102core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2026-03-3105833102core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2026-03-3105833102core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2026-03-3105833102core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2026-03-3105833102core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3105833102core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3105833102core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3105833102core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3105833102core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3105833102core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3105833102core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3105833102core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3105833102core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3105833102bus:Director12025-04-012026-03-3105833102bus:Director22025-04-012026-03-3105833102bus:Director32025-04-012026-03-3105833102bus:Director42025-04-012026-03-31

HERTS HEALTH LIMITED

Registered Number
05833102
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2026

HERTS HEALTH LIMITED
Company Information
for the year from 1 April 2025 to 31 March 2026

Directors

BAGG, William, Dr
BYRNE, Alexandra Rachel, Dr
GLEKIN, Sammy, Dr
TRIVEDI, Rushikesh Yogesh

Registered Address

Ramsay Brown Llp The Brentano Suite
Solar House, 915 High Road
North Finchley
N12 8QJ

Registered Number

05833102 (England and Wales)
HERTS HEALTH LIMITED
Balance Sheet as at
31 March 2026

Notes

2026

2025

£

£

£

£

Fixed assets
Tangible assets34,1204,847
4,1204,847
Current assets
Debtors452,71558,888
Cash at bank and on hand445,527335,564
498,242394,452
Creditors amounts falling due within one year5(213,933)(111,615)
Net current assets (liabilities)284,309282,837
Total assets less current liabilities288,429287,684
Net assets288,429287,684
Capital and reserves
Called up share capital985985
Share premium57,45257,452
Profit and loss account229,992229,247
Shareholders' funds288,429287,684
The financial statements were approved and authorised for issue by the Board of Directors on 24 June 2026, and are signed on its behalf by:
BYRNE, Alexandra Rachel, Dr
Director
Registered Company No. 05833102
HERTS HEALTH LIMITED
Notes to the Financial Statements
for the year ended 31 March 2026

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Interest income
Interest income is recognised using the effective interest rate method.
Defined contribution pension plan
The company operates a defined contribution pension plan for the benefit of its employees. Contributions are recognised as expenses as they become payable. Differences between contributions payable in the year and those actually paid are recognised as either prepayments or accruals in the balance sheet. The assets of the defined contribution pension scheme are held separately from those of the company in an independently administered fund.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Reducing balance (%)Straight line (years)
Plant and machinery-4
Fixtures and fittings15-
Office Equipment15-
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less. Bank overdrafts are disclosed separately. For the purpose of the cash flow statement, bank overdrafts form an integral part of the company's cash management and are included as a component of cash and cash equivalents.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Share capital
Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new ordinary shares or options are shown in equity as a deduction, net of tax, from the proceeds.
2.Average number of employees

20262025
Average number of employees during the year1514
3.Tangible fixed assets

Total

£
Cost or valuation
At 01 April 2519,217
At 31 March 2619,217
Depreciation and impairment
At 01 April 2514,370
Charge for year727
At 31 March 2615,097
Net book value
At 31 March 264,120
At 31 March 254,847
4.Debtors: amounts due within one year

2026

2025

££
Trade debtors / trade receivables49,78857,420
Prepayments and accrued income2,9271,468
Total52,71558,888
5.Creditors: amounts due within one year

2026

2025

££
Trade creditors / trade payables158,81143,020
Taxation and social security2363,742
Other creditors486486
Accrued liabilities and deferred income54,40064,367
Total213,933111,615
6.Directors advances, credits and guarantees
As at the year-end, the company owed the director £486 (2025: £486).
7.Share capital
Alloted, called up and fully paid: 985 (2025 : 985) Ordinary of £1 each